vs

Side-by-side financial comparison of FEDERAL AGRICULTURAL MORTGAGE CORP (AGM) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

FEDERAL AGRICULTURAL MORTGAGE CORP is the larger business by last-quarter revenue ($107.5M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 6.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.1%).

The Federal Agricultural Mortgage Corporation, also known as Farmer Mac, is a stockholder-owned, federally chartered corporation established by the U.S. Congress in 1988 under the Agricultural Credit Act of 1987. It was created to establish a secondary market for agricultural real estate and housing mortgage loans, to increase liquidity and the availability of long-term, stable credit for farmers, ranchers, and rural communities.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

AGM vs PBYI — Head-to-Head

Bigger by revenue
AGM
AGM
1.4× larger
AGM
$107.5M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+21.6% gap
PBYI
27.7%
6.1%
AGM
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
7.1%
AGM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGM
AGM
PBYI
PBYI
Revenue
$107.5M
$75.5M
Net Profit
Gross Margin
69.3%
Operating Margin
56.3%
22.7%
Net Margin
Revenue YoY
6.1%
27.7%
Net Profit YoY
EPS (diluted)
$3.69
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGM
AGM
PBYI
PBYI
Q4 25
$107.5M
$75.5M
Q3 25
$104.0M
$54.5M
Q2 25
$102.6M
$52.4M
Q1 25
$94.3M
$46.0M
Q4 24
$101.3M
$59.1M
Q3 24
$90.3M
$80.5M
Q2 24
$89.9M
$47.1M
Q1 24
$93.7M
$43.8M
Net Profit
AGM
AGM
PBYI
PBYI
Q4 25
Q3 25
$55.0M
$8.8M
Q2 25
$54.8M
$5.9M
Q1 25
$49.7M
$3.0M
Q4 24
$56.5M
Q3 24
$49.8M
$20.3M
Q2 24
$47.1M
$-4.5M
Q1 24
$53.7M
$-4.8M
Gross Margin
AGM
AGM
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
AGM
AGM
PBYI
PBYI
Q4 25
56.3%
22.7%
Q3 25
64.1%
17.6%
Q2 25
63.8%
12.7%
Q1 25
66.9%
8.7%
Q4 24
67.5%
22.6%
Q3 24
69.0%
27.4%
Q2 24
65.9%
-4.6%
Q1 24
72.8%
-5.3%
Net Margin
AGM
AGM
PBYI
PBYI
Q4 25
Q3 25
52.9%
16.2%
Q2 25
53.4%
11.2%
Q1 25
52.6%
6.5%
Q4 24
55.8%
Q3 24
55.2%
25.2%
Q2 24
52.4%
-9.6%
Q1 24
57.4%
-11.0%
EPS (diluted)
AGM
AGM
PBYI
PBYI
Q4 25
$3.69
$0.26
Q3 25
$4.44
$0.17
Q2 25
$4.48
$0.12
Q1 25
$4.01
$0.06
Q4 24
$4.62
$0.40
Q3 24
$3.86
$0.41
Q2 24
$3.68
$-0.09
Q1 24
$4.28
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGM
AGM
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$30.8B
$22.7M
Stockholders' EquityBook value
$1.7B
$130.3M
Total Assets
$35.4B
$216.3M
Debt / EquityLower = less leverage
17.93×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGM
AGM
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$842.1M
$96.7M
Q2 24
$923.0M
$96.8M
Q1 24
$745.1M
$107.2M
Total Debt
AGM
AGM
PBYI
PBYI
Q4 25
$30.8B
$22.7M
Q3 25
$29.2B
$34.0M
Q2 25
$28.9B
$45.3M
Q1 25
$28.0B
$56.7M
Q4 24
$27.5B
$68.0M
Q3 24
$27.2B
$79.3M
Q2 24
$26.8B
$90.7M
Q1 24
$26.8B
$102.0M
Stockholders' Equity
AGM
AGM
PBYI
PBYI
Q4 25
$1.7B
$130.3M
Q3 25
$1.7B
$115.3M
Q2 25
$1.5B
$104.7M
Q1 25
$1.5B
$97.1M
Q4 24
$1.5B
$92.1M
Q3 24
$1.5B
$71.1M
Q2 24
$1.5B
$48.5M
Q1 24
$1.5B
$51.0M
Total Assets
AGM
AGM
PBYI
PBYI
Q4 25
$35.4B
$216.3M
Q3 25
$33.4B
$202.9M
Q2 25
$33.0B
$194.9M
Q1 25
$31.8B
$196.2M
Q4 24
$31.3B
$213.3M
Q3 24
$30.6B
$220.7M
Q2 24
$30.2B
$205.0M
Q1 24
$29.8B
$214.1M
Debt / Equity
AGM
AGM
PBYI
PBYI
Q4 25
17.93×
0.17×
Q3 25
17.31×
0.30×
Q2 25
18.70×
0.43×
Q1 25
18.39×
0.58×
Q4 24
18.48×
0.74×
Q3 24
18.60×
1.12×
Q2 24
17.87×
1.87×
Q1 24
18.11×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGM
AGM
PBYI
PBYI
Operating Cash FlowLast quarter
$80.1M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGM
AGM
PBYI
PBYI
Q4 25
$80.1M
$14.4M
Q3 25
$74.2M
$9.7M
Q2 25
$-47.7M
$14.1M
Q1 25
$-49.8M
$3.6M
Q4 24
$612.6M
$15.6M
Q3 24
$-44.4M
$11.0M
Q2 24
$56.1M
$1.0M
Q1 24
$233.3M
$11.2M
Free Cash Flow
AGM
AGM
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$607.4M
$15.6M
Q3 24
$-44.4M
$11.0M
Q2 24
$52.6M
$1.0M
Q1 24
$231.7M
FCF Margin
AGM
AGM
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
599.8%
26.4%
Q3 24
-49.2%
13.7%
Q2 24
58.5%
2.1%
Q1 24
247.3%
Capex Intensity
AGM
AGM
PBYI
PBYI
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.0%
Q1 25
0.0%
0.1%
Q4 24
5.2%
0.0%
Q3 24
0.1%
0.0%
Q2 24
4.0%
0.0%
Q1 24
1.7%
0.0%
Cash Conversion
AGM
AGM
PBYI
PBYI
Q4 25
Q3 25
1.35×
1.10×
Q2 25
-0.87×
2.41×
Q1 25
-1.00×
1.21×
Q4 24
10.84×
Q3 24
-0.89×
0.54×
Q2 24
1.19×
Q1 24
4.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons